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Summary 
 
Whereas ligation of DNAM-1 adhesion molecule triggers cytotoxicity 
mediated by normal NK and T cells, this function was defective in NK cell 
clones from leukocyte adhesion deficiency syndrome.  However, genetic 
reconstitution of cell surface expression of LFA-1 restored the ability of 
DNAM-1 to initiate anti-DNAM-1 mAb induced cytotoxicity, indicating a 
functional relationship between DNAM-1 and LFA-1.  Further studies 
demonstrated that LFA-1 physically associates with DNAM-1 in NK cells 
and anti-CD3 mAb stimulated T cells, for which serine phosphorylation of 
DNAM-1 plays a critical role.  In addition, cross-linking of LFA-1 induces 
tyrosine phosphorylation of DNAM-1, for which the fyn protein tyrosine 
kinase is responsible.  These results indicate that DNAM-1 is involved in 
the LFA-1-mediated intracellular signals. 
 
 
Running Title: 
Association of LFA-1 and DNAM-1 
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Introduction 
 During a successful cellular response, several families of adhesion 
molecules participate not only in intercellular binding but also in signal 
transduction for effector cell activation or deactivation (Springer, 1990; Dustin 
and Springer, 1991; Hynes, 1992; Hogg and Landis, 1993).  The β2 integrin 
adhesion molecules are composed of a common β chain (CD18) that non-
covalently associates with α subunits, including leukocyte function-associated 
antigen-1 (LFA-1; αLβ2, CD11a/CD18), Mac-1 (CD11b/CD18), p150,95 
(CD11c/CD18), and αdβ2 (CD11d/CD18) (reviewed inSpringer et al., 1987).  
The physiological importance of β2 integrin adhesion molecules is revealed by 
an inherited disorder known as leukocyte adhesion deficiency (LAD) in humans 
and in cattle, in which defects in the β2 genes cause a loss of expression of all 
the β2 integrins, resulting in profound defects in cellular adhesion (Krensky et 
al., 1985; Anderson and Springer, 1987; Kishimoto et al., 1987; Arnaout, 1990; 
Shuster et al., 1992).  In these patients, many adhesion-dependent functions 
of leukocytes are abnormal, including adherence to endothelium, aggregation 
and chemotaxis, phagocytosis, and cytotoxicity mediated by neutrophils, 
macrophage, NK cells, and T lymphocytes.  Mice with disrupted CD18 genes 
have demonstrated a phenotype closely resembling LAD patients (Scharffetter-
Kochanek et al., 1998).  
 The αLβ2 integrin, LFA-1 (CD11a/CD18), is expressed on most 
leukocytes and mediates cell-cell adhesion upon binding to its ligands, the 
intercellular adhesion molecules (ICAM)-1 (CD54), ICAM-2 (CD102), or ICAM-3 
(CD50) (Staunton et al., 1988; Staunton et al., 1989; Fawcett et al., 1992).  
Circulating peripheral blood leukocytes generally express an inactive form of 
LFA-1.  Once leukocytes are activated, for instance through the T cell antigen 
receptor (TCR) upon recognition of a peptide antigen or by phorbol 12-myristate 
13-acetate (PMA), intracellular signals (referred to as ‘inside-out’ signals) cause 
a conformational change in LFA-1, resulting in intercellular binding and effector 
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cell function (van Kooyk et al., 1989; Dustin and Springer, 1989).  The 
cytoplasmic regulatory protein, cytohesin, is a key molecule involved in this 
process (Kolanus et al., 1996). 
 Antibody cross-linking of cell surface LFA-1 induces intracellular signals 
(referred as to ‘outside-in’ signals) (Kanner et al., 1993; Arroyo et al., 1994), 
suggesting that ligand binding may also affect cellular functions such as 
apoptosis, cytotoxicity, proliferation, cytokine production and antigen 
presentation (Koopman et al., 1994; Moy and Brian, 1992; Springer, 1990; 
Lanier and Phillips, 1993).  Blocking the interaction between LFA-1 and its 
ICAM ligands induces tolerance against cardiac allografts in mice (Isobe et al., 
1992) and studies using mice with disrupted CD11a or CD18 genes have 
indicated a requirement for LFA-1 in T cell proliferation induced by the 
TCR/CD3 complex (Schmits et al., 1996; Scharffetter-Kochanek et al., 1998).  
These observations indicate that LFA-1 not only mediates intercellular binding 
but also may deliver costimulatory signals in T lymphocytes.  In contrast with 
‘inside-out’ signaling, little is known about the intracellular signals initiated by 
LFA-1 ligation. 
 The  leukocyte adhesion molecule DNAM-1, a member of the 
immunoglobulin superfamily, is constitutively expressed on the majority of T 
lymphocytes, natural killer (NK) cells and monocytes (Shibuya et al., 1996).  
Depending on the experimental conditions, monoclonal antibodies against 
DNAM-1 can function as agonists, triggering NK or T cell-mediated cytotoxicity 
and cytokine production, or as antagonists, blocking NK or T cell responses 
against target cells expressing a putative DNAM-1 ligand (Shibuya et al., 1996).  
Upon mAb cross-linking, tyrosine residues in the cytoplasmic domain of DNAM-
1 are phosphorylated (Shibuya et al., 1996), suggesting that DNAM-1 
transduces an activation signal.  In this study, we report deficient DNAM-1 
function in NK cells from a LAD patient and have explored the relationship 
between LFA-1 and DNAM-1 signaling. 
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Results 
Defective DNAM-1 function in NK cells obtained from a patient with 
Leukocyte Adhesion Deficiency (LAD) 
 mAbs against CD2 and CD16 are able to trigger cytolytic activity when 
NK cells are co-cultured with target cells expressing Fc receptors (Schmidt et al., 
1985, Siliciano et al., 1985).  Similarly, anti-DNAM-1 mAb is capable of 
inducing re-directed cytolysis of Fc receptor-bearing mouse mastocytoma P815 
mediated by CTL and NK clones (Shibuya et al., 1996).  P815 cells express a 
murine ICAM that interacts with LFA-1 on human T and NK cells (Cayabyab et 
al., 1994), suggesting that LFA-1 might be involved in anti-DNAM-1 mAb-
induced cytolysis against P815.  
  To investigate the involvement of LFA-1 in anti-DNAM-1 mAb-induced 
cytolysis, NK clones were established from the peripheral blood of a patient with 
leukocyte adhesion deficiency (LAD) (Anderson and Springer, 1987).  The NK 
clones expressed normal levels of CD2, CD16, CD56, and DNAM-1 antigens 
(not shown), but completely lacked the expressions of the β2-integrins LFA-1 
(CD11a/CD18), MAC-1 (CD11b/CD18), and p150/95 (CD11c/CD18) (Fig. 1A).  
While these NK cell clones demonstrated normal cytolytic activity against 
certain tumor cell targets, such as K562, we observed that unlike NK clones 
from healthy donors, they were unable to mediate antibody-redirected 
cytotoxicity against Fc receptor bearing targets (e.g. P815) in the presence of 
anti-DNAM-1 mAb (Fig. 1B).  This deficiency was selective for DNAM-1, 
because antibody-redirected killing triggered by mAbs against other activating 
NK cell surface receptors, for example CD16 (Fig. 1B) or CD2 (not shown) were 
normal.  This finding suggested that DNAM-1-mediated cytolysis by the LAD 
NK clones may require the participation of LFA-1, either for effector - target cell 
adhesion or signaling. 
 Although the loss of β2-integrin expression in LAD disease is attributed to 
heterogeneous defects in the common β subunit CD18 (Anderson and Springer, 
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1987), CD18 gene transfer restores the expression and function of LFA-1 
regardless of the site of the molecular defect (Hibbs et al., 1990; Bauer et al., 
1998).  To examine the requirement of LFA-1 for anti-DNAM-1 mAb-induced 
cytolysis by NK cells, we infected a LAD NK cell clone with an amphotropic 
retrovirus containing a wild-type CD18 cDNA.  These retrovirus-transduced NK 
cells stably expressed LFA-1 (CD11a/CD18) at a level comparable to NK cells 
from healthy individuals (not shown), but these cells did not express either Mac-
1 (CD11b/CD18) or p150/95 (CD11c/CD18) (Fig 1A).  Although the precise 
mechanism is unclear, the dominant expression of LFA-1 was also observed in 
the previous report after retrovirus-mediated CD18 gene-transfer in LAD cells 
(Bauer et al., 1998).  As demonstrated in Fig 1B, genetic transfer of CD18 into 
the LAD NK cell clone completely restored anti-DNAM-1 mAb-induced 
cytotoxicity against P815 target cells.  CD18 was responsible for this function 
because the anti-DNAM-1 mAb induced killing mediated by the reconstituted 
LAD NK clone, as well as normal NK cells, was prevented in the presence of 
F(ab')2 fragments of anti-CD18 mAb. 
 Our prior observations demonstrated that co-culture of normal NK clones 
or T clones with anti-DNAM-1 mAb-pre-coated P815 target cells resulted in 
tyrosine phosphorylation of DNAM-1 (Shibuya et al., 1996).  DNAM-1 
phosphorylation was completely inhibited in the presence of F(ab')2 fragments 
of anti-CD18 (not shown).  Tyrosine phosphorylation of DNAM-1 was not 
induced by co-culture of the LAD NK clones with anti-DNAM-1 mAb-pre-coated 
P815 cells (Fig 1C).  However, reconstitution of LFA-1 expression on the LAD 
NK clone by CD18 gene transfer restored the DNAM-1 tyrosine phosphorylation 
induced by co-culture with anti-DNAM-1 pre-coated P815 target cells.  Again, 
this was completely inhibited in the presence of F(ab')2 fragments of anti-CD18 
(Fig 1C).  These results indicate a functional relationship between LFA-1 and 
DNAM-1. 
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LFA-1 physically associates with DNAM-1 in NK cells 
 The functional relationship between LFA-1 and DNAM-1 led us to 
examine whether DNAM-1 physically associates with β2 integrins.  The CD18-
reconstituted LAD NK clones expressed LFA-1 (CD11a/CD18 ), but not 
substantial levels of either Mac-1 (CD11b/CD18) or p150/95 (CD11c/CD18).  
By contrast, normal peripheral blood NK cells express all these β2 integrins (not 
shown) (Timonen et al., 1988).  NK cells isolated from the peripheral blood of a 
healthy individual were lysed in 1% digitonin buffer and immunoprecipitated with 
anti-CD18, anti-CD11a, anti-CD11b, or anti-CD11c and the isolated proteins 
were analyzed by immunoblotting with anti-DNAM-1 mAb.   As demonstrated 
in Fig 2, DNAM-1 was co-immunoprecipitated with CD11a and CD18, but not 
CD11b or CD11c, suggesting that DNAM-1 associates preferentially with the 
CD11a α chain or the CD11a/CD18 heterodimer.   
 
CD3 stimulation of T cell induces association of LFA-1 with DNAM-1 
 Anti-DNAM-1 mAb can trigger cytotoxicity mediated by CTL, as well as 
NK cells (Shibuya, et al., 1996); however, anti-DNAM-1 mAb does not induce 
cytotoxicity mediated by resting T cells without prior in vitro activation (not 
shown), raising the issue of whether DNAM-1 and LFA-1 associate in activated, 
but not resting, T cells.  Resting T cells separated from the peripheral blood of 
healthy donors were lysed in digitonin buffer and immunoprecipitated with anti-
CD18  mAb.  Strikingly, DNAM-1 did not co-immunoprecipitate with LFA-1 
using lysates prepared from resting T cells (Fig 3A).  Since antigen binding by 
TCR or stimulation with anti-CD3 mAb induces a conformational change of LFA-
1 (van Kooyk et al., 1989; Dustin and Springer, 1989), we examined whether 
anti-CD3 mAb induces association of LFA-1 with DNAM-1.  As demonstrated 
in Fig 3A, after T cell stimulation with anti-CD3 mAb DNAM-1 was co-
immunoprecipitated with LFA-1.  The anti-CD3 induced association of LFA-1 
and DNAM-1 was prevented in the presence of a specific inhibitor of PKC (Fig. 
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3A).  In support of the concept that PKC activation is required for LFA-1 
association with DNAM-1, we observed that DNAM-1 was co-
immunoprecipitated with LFA-1 upon stimulation of resting T cells with PMA in 
the absence of anti-CD3 mAb (Fig. 3A).  Prior studies have shown that 
activation of PKC causes serine phosphorylation of DNAM-1 on residue 329 in 
the cytoplasmic domain and that S329 phosphorylation of DNAM-1 increases its 
ligand binding activity (Shibuya et al., 1998).  Therefore, resting T cells were 
metabolically labeled with [32P]orthophosphate, stimulated with anti-CD3 mAb 
or PMA, lysed, and immunoprecipitated with anti-DNAM-1 mAb.  As shown in 
Fig. 3B, treatment of resting T cells with either anti-CD3 mAb or PMA resulted in 
phosphorylation of DNAM-1, suggesting that phosphorylation may play an 
important role in the association of DNAM-1 with LFA-1.  By contrast, 
stimulation with pervanadate did not induce or increase the association of LFA-
1 with DNAM-1 in resting or anti-CD3 activated T cells, respectively (Fig 3C), 
indicating that  tyrosine phosphorylation of DNAM-1 or LFA-1 may not be 
required for this interaction. 
 
S329 of DNAM-1 plays a critical role for the association of LFA-1 with 
DNAM-1 in T cells 
 Unlike the situation with resting T cells, DNAM-1 was co-
immunoprecipitated with LFA-1 in lysates prepared from the human T and NK 
cell leukemias Jurkat and NKL, respectively (Fig 4A), as well as from freshly 
isolated NK cells (Fig 2), suggesting a constitutive associate of DNAM-1 and 
LFA-1 in these cell types.  Our prior findings that activated PKC 
phosphorylates the serine at residue 329 in the cytoplasmic domain of DNAM-1 
and increases avidity of DNAM-1-mediated adhesion with cells bearing its 
ligand (Shibuya et al., 1998) suggested that phosphorylated S329 may be 
involved in the association of DNAM-1 with LFA-1.  To test this hypothesis, 
Jurkat cells were transfected with wild-type DNAM-1 cDNA (WT) or a site-
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directed mutant of DNAM-1 at S329 (S-F329), both tagged with the Flag peptide 
epitope at the N-terminus.   The transfectants were examined for the 
association of LFA-1 with endogenous and transfected DNAM-1 molecules.  
Fig. 4B shows that anti-LFA-1 co-immunoprecipitated both endogenous and 
transfected wild-type DNAM-1.  By contrast, the mutant S-F329  DNAM-1 
glycoprotein was not co-immunoprecipitated with LFA-1.  To confirm the 
phosphorylation of S329 of DNAM-1, the Jurkat transfectants were 
metabolically labeled with [32P]orthophosphate and DNAM-1 proteins were 
immunoprecipitated with anti-Flag mAb.  As shown in Figure 4C, the DNAM-1 
proteins in Jurkat cells transfected with WT DNAM-1, but not with S-F329 
mutant DNAM-1, were phosphorylated, consistent with the conclusion that LFA-
1 associates with wild-type DNAM-1, but not with S-F329 mutant DNAM-1.  
These results indicate that phosphorylated S329 plays a critical role in the 
association of LFA-1 with DNAM-1. 
 
Cross-linking of LFA-1 induces tyrosine phosphorylation of DNAM-1 and 
fyn in activated T cells 
 Because the cytoplasmic domain of DNAM-1 contains tyrosines which 
are phosphorylated by stimulation with pervanadate in T cells and NK cells 
(data not shown), we examined whether directly cross-linking LFA-1 induces 
tyrosine phosphorylation of DNAM-1.  Fig 5A demonstrates that ligation of 
LFA-1 with anti-CD18 mAb significantly induced tyrosine phosphorylation of 
DNAM-1 in anti-CD3 activated T cells, whereas it did not induce the 
phosphorylation of DNAM-1 in resting, non-stimulated T cells, where LFA-1 is 
not associated with DNAM-1 (Fig. 3A).  It should be noted that low levels of 
tyrosine phosphorylated DNAM-1 were also detected in T cells activated with 
anti-CD3 mAb alone (Fig. 5A), possibly because the activated T cells expressed 
not only LFA-1, but also its ligand ICAM-1.  These results suggest that cross-
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linking of LFA-1 with antibody or possibly with its ligand results in tyrosine 
phosphorylation of DNAM-1 in activated T cells. 
 These results led us to search for the protein tyrosine kinases (PTK) 
involved in the phosphorylation of DNAM-1.  The amino acid sequence 
REDIY322VNY in the cytoplasmic domain of DNAM-1 is a possible 
phosphorylation site for a src-family PTK (Shibuya et al., 1996).  Therefore, we 
looked for a src family PTK expressed in T cells that was phosphorylated in 
response to cross-linking of LFA-1.  No PTK tested was phosphorylated by 
anti-LFA-1 ligation using resting, non-stimulated T cells (Fig 5A and not shown).  
Stimulation of resting T cells with anti-CD3 mAb alone induced tyrosine 
phosphorylation of lck and fyn, consistent with the previous reports that these 
PTK are regulated by the CD3/TcR complex (Iwashima et al., 1994; Samelson 
et al., 1990).  However, co-ligation of both LFA-1 and CD3 induced or 
augmented tyrosine phosphorylation of fyn, but not of lck, implicating the fyn 
protein tyrosine kinase in the activation process.  
 
DNAM-1 binds fyn  
 To address the relationship of fyn with LFA-1 and DNAM-1, resting T 
cells were stimulated with anti-CD3 and/or pervanadate, were lysed and 
immunoprecipitated with either anti-CD18 or anti-DNAM-1.  As shown in Fig 5B, 
fyn was co-immunoprecipitated with DNAM-1, but not with CD18, in T cells 
treated with pervanadate, indicating that fyn is primarily recruited by DNAM-1, 
but not LFA-1.  Fyn  was also co-immunoprecipitated with DNAM-1 from T 
cells activated by anti-CD3 (Fig 5B), consistent with the results that tyrosine 
phosphorylation of fyn was induced by anti-CD3 stimulation alone (Fig 5A).  
Because fyn was co-immunoprecipitated with LFA-1 only under conditions that 
induced association of LFA-1 and DNAM-1, it is likely that this kinase is 
interacting with DNAM-1 rather than LFA-1, although we can not exclude 
intermediate adapter molecules in the process. 
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Fyn phosphorylates Y322 of DNAM-1 
 To determine the site of phosphorylated tyrosine in the DNAM-1 
cytoplasmic domain, Jurkat cells were transfected with wild type (WT) or a site-
directed mutant (Y-F322) DNAM-1 , both tagged with Flag at N-terminus.  
These transfectants were stimulated with pervanadate and the Flag-tagged 
wild-type and Y-F322 DNAM-1 proteins were immunoprecipitated with anti-Flag 
mAb and then immunoblotted with anti-phosphotyrosine or anti-fyn.  Fig 6 
shows that phosphorylated tyrosines were detected in wild-type Flag-tagged 
DNAM-1, but not in Y-F322 DNAM-1, indicating that Y322 of DNAM-1 is the site 
phosphorylated in response to pervanadate stimulation.  Of note,  fyn was co-
immunoprecipitated with both wild-type and Y-F322  mutant DNAM-1 protein, 
suggesting that fyn may phosphorylate the Y322 of DNAM-1. 
 To examine whether fyn is responsible for phosphorylation of  the 
tyrosine at residue 322 of DNAM-1, COS-7 cells were co-transfected with wild-
type or T-F322 mutant DNAM-1 and either with wild-type, kinase dead, or 
constitutively active fyn and DNAM-1 proteins were immunoblotted with anti-
phosphotyrosine.  As demonstrated in Fig 7, the wild-type DNAM-1 was 
tyrosine phosphorylated in the transfectant with wild-type and constitutively 
active, but not kinase dead, fyn.  By contrast,  the tyrosine phopshorylation of 
Y-F322 mutant DNAM-1 was not detected in the transfectant with any type of 
fyn.  These results indicate that  fyn is likely a responsible kinase for 
phosphorylation of Y322 of DNAM-1. 
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Discussion 
 In this study, we demonstrate that initiation of cytotoxicity function by 
cross-linking the DNAM-1 receptor is dependent upon a functional interaction 
with LFA-1.  Genetic restoration of LFA-1 expression in NK cells established 
from a LAD patient rendered the DNAM-1 molecule functional, thus providing 
formal evidence for this association. This observation prompted further studies 
to understand the molecular basis for this phenomenon.  We have shown  
that LFA-1 physically associates with DNAM-1 in normal peripheral NK cells.  
Moreover, stimulation of resting T cells with either anti-CD3 or PMA induces the 
association of LFA-1 and DNAM-1 and this requires phosphorylation of S329 in 
DNAM-1.  Presently, it is uncertain whether this reflects a direct interaction or 
an indirect association via adaptor molecules or the cytoskeleton.  Nonetheless, 
once LFA-1 and DNAM-1 associate, cross-linking LFA-1 results in the tyrosine 
phosphorylation of DNAM-1. DNAM-1 phosphorylation on tyrosine was not 
induced by cross-linking DNAM-1 with mAb but requires the ligand binding of 
LFA-1 (Fig 1C and our unpublished data).  We have demonstrated that cross-
linking LFA-1 also augmented tyrosine phosphorylation of  fyn and this kinase 
is likely responsible for DNAM-1 phosphorylation at residue 322.  Taken 
together, these results suggest that initiation of cytotoxicity function by cross-
linking the DNAM-1 receptor requires tyrosine phosphorylation of DNAM-1 
induced by fyn which is activated by LFA-1.  Further studies using a genetic 
reconstitution model will be required to determine whether fyn is involved in the 
function of DNAM-1 receptor. 
 The signaling pathways involved in LFA-1 function are complex and 
incompletely understood.  Prior studies have demonstrated that the LFA-1-
mediated cell adhesion is enhanced in T cells after stimulation of the TCR or 
upon activation of PKC by phorbol esters (van Kooyk et al., 1989; Dustin and 
Springer, 1989).  We have previously reported that PKC activation by PMA 
also increases ligand binding activity of DNAM-1 (Shibuya et al., 1998).  In this 
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study, we have shown that, under these conditions that activate T cells,  these 
adhesion molecules form a physical complex.  At present, it is uncertain how 
are adhesion and intracellular signaling mediated by the complex of LFA-1 and 
DNAM-1 regulated following activation of T cells.  To address this issue, it is 
essentially required to identify the DNAM-1 ligand and determine the structural 
requirement involved in DNAM-1 binding. 
 There are evidences that β1 (α1β1 and α5β1) and β3 (αIIbβ3 and αVβ3) 
integrins associate with a membrane adaptor molecule caveolin-1 (Wary et al., 
1998) and CD47 (Lindberg et al., 1993), respectively.  Our studies indicate the 
physical and functional association of DNAM-1with αLβ2 integrin LFA-1.  Many 
signal transducing molecules are also involed in LFA-1 function.  For example, 
cross-linking of LFA-1 by antibodies or potentially ligand results in the activation 
of protein tyrosine kinases in T cells or NK cells (Sugie et al., 1995, Kanner, 
1996, Rodriguez-Fernandezthe et al., 1999), the stimulation of PLC-γ1 (Kanner 
et al., 1993) and there are evidence for co-immunoprecipitation of LFA-1 with 
ZAP70 (Soede et al., 1998) and with cytohesin (Kolanus et al., 1996) in 
activated T cells.  In addition, co-clustering has been demonstrated for the 
LFA-1-FcγRIIIb pair on neutrophils (Zhou et al., 1993).  Furthermore, LFA-1-
dependent activation results in translocation of PKC to the cytoskeleton in T 
cells (Volkov et al., 1998).   Further studies will be required to determine the 
relationship of these signal transducing molecules with DNAM-1 and fyn to 
elucidate the role of these molecules in LFA-1 function. 
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Experimental Procedures 
 Cells and Reagents.  Resting T cells were isolated from the peripheral 
blood of healthy volunteers, as described previously (Azuma et al., 1992).  
Resting CD3-CD56+ NK cells (CD3-CD56+) were purified by cell sorting using 
flow cytometry from the peripheral blood of healthy volunteers.  NK clones 
were established from the peripheral blood of healthy donors or a patient with 
leukocyte adhesion molecule deficiency using the culture conditions described 
previously (Yssel et al., 1984) and 100 IU/ml recombinant IL-2 as a growth 
factor.  Jurkat is a human T cell leukemia cell line.  NKL is a human NK 
leukemia cell line generously provided by Dr. Mike Robertson (U. Indianapolis) 
(Robertson et al., 1996).  P815 is a murine mastocytoma cell line.  PMA was 
purchased from Sigma (St. Louis, Missouri) and dissolved in DMSO, which did 
not exceed 0.1% in the assay medium. 
 
 Abs and Flow Cytometry.  Control IgG, anti-CD3 (Leu 4 mAb), anti-
CD16 (Leu 11a mAb), anti-CD11a (L7 mAb), anti-CD11b (Leu 15 mAb), anti-
CD11c (Leu M5 mAb), anti-CD56 (Leu 19 mAb), and anti-CD18 (L130 mAb) 
were generously provided by Becton Dickinson Immunocytometry Systems 
(San Jose, CA).  Anti-DNAM-1 mAb (DX11) were generated as described 
(Shibuya et al., 1996).  Anti-phosphotyrosine mAb (4G10) was purchased from 
Upstate Biotechnology Inc., Lake Placid, NY.  Anti-Flag mAb was purchased 
from Sigma.  Anti-protein tyrosine kinases lck and fyn are polyclonal rabbit Abs 
that were gifts from Dr. Joe Bolen (DNAX).  F(ab')2 fragments of anti-CD18 
were prepared as described (Shibuya et al., 1996).  Purity of the F(ab')2 
fragments were determined by SDS-PAGE.  Methods of immunofluorescent 
staining and flow cytometry have been described previously (Lanier and 
Recktenwald, 1991).  
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 Cytotoxicity assay.  Tumor cell lines (~ 1.5 x 106 cells) were labeled 
with 100 uCi 51Cr for 2 h, washed, and used as targets in a 4-h radioisotope 
release cytotoxicity assay, as described (Lanier et al., 1983).  Data are 
expressed as the means of triplicate cultures.  Spontaneous radioisotope 
release was typically <10% of total 51Cr release.  Percent cytolysis was 
calculated as: 
cpm specific 51Cr release - cpm spontaneous release        x 100 
cpm total 51Cr release - cpm spontaneous release        
 
 Genetic reconstitution of LAD NK cell clones.  A cDNA containing the 
open reading frame of CD18 was generated by PCR using a wild-type CD18 
cDNA plasmid as the template.  The PCR products were subcloned into a 
retroviral vector pMX-neo (Onishi et al. , 1996) (kindly provided by Toshio 
Kitamura, DNAX) with cloning sites of Bam H1(5') and Not 1 (3').  Phoenix-
amphotropic packaging cells (Kinsella and Nolan, 1996) (generously provided 
by Gary Nolan, Stanford) were transfected with the CD18 cDNA in the retroviral 
vector using lipofectamine (GibcoBRL), as described previously (Kitamura et al., 
1995, Onishi et al., 1996).  LAD NK clones were infected with the CD18 
retrovirus stock.  Two days after infection, the cells were analyzed and CD18 
expressing cells were sorted by flow cytometry and expanded in the culture 
conditions described previously (Yssel et al., 1984).  Expression of CD18, 
CD11a, CD11b, and CD11c were analyzed by flow cytometry. 
 
 Establishment of Jurkat transfectants with wild type and mutant DNAM-1.  
Wild type DNAM-1 cDNA was subcloned into the pFLAG-CMV-1 vector 
(Scientific Imaging Systems, Rochester, NY) with cloning sites of Sal 1 (5') and 
Not 1 (3').  To generate site-specific DNAM-1 mutants at residues Y322 or 
S329, antisense PCR primers, which contained a codon for F (TTT) instead of 
Y322 (TAT) or S329 (TCT), were designed.  The PCR products were 
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subcloned into the pFLAG-CMV-1 vector with the same cloning sites as the wild 
type cDNA.  All mutant cDNAs were verified by sequencing.  Jurkat cells were 
transfected with the wild type or site-specific mutant DNAM-1 using DMRIE-C 
(GibcoBRL, Gaithersburg, MD).  Expression of wild type and mutant DNAM-1 
were analyzed by flow cytometry using anti-Flag mAb (Sigma). 
 
 Establishment of COS-7 co-transfectants with DNAM-1 and fyn.    
COS-7 cells were co-transfected with the wild type or site-specific mutant 
DNAM-1, described above, together with either wild type, kinase dead (having 
the site-directed mutation of M instead of K at residue 296) or constitrutively 
active (having the site-directed mutation of F instead of Y at residue 528) 
(Takeuchi et al., 1993)  fyn (kindly provided by Tadashi Yamamoto, University 
of Tokyo) using DMRIE-C.  Expression of DNAM-1 and fyn were analyzed by 
immunoblotting. 
 
 Biochemistry.  To examine the association of molecules with LFA-1 or DNAM-
1, cells were stimulated or not with plastic-precoated mAbs for 2 min, and/or 100 mM 
sodium pervanadate for 10 min at 37oC (O'Shea et al., 1992).  Cells were lysed in 1% 
digitonin (Sigma) buffer ((0.12% triton-100 (Katayama Pure Chemical, Osaka, Japan), 
150 mM NaCl, 20 mM triethanolamine (Katayama Pure Chemical), protease inhibitors 
(1 mM PMSF and 20 Kallikrein inhibitor U/ml aprotinin) and phosphatase inhibitors (1 
mM EGTA, 10 mM NaF, 1 mM Na4PO7, 0.1 mM β-glycerophosphatase, 1 mM 
Na3VO4)).  The lysates were immunoprecipitated with anti-CD18, anti-DNAM-1 
(DX11 mAb), anti-Flag or control Ig and proteins were separated by sodium dodecyl 
sulfate (SDS) polyacrylamide gel electrophoresis (PAGE).  Immunoprecipitates were 
transferred (100V, 1 hr in 25 mM Tris, 195 mM glycine, 20% methanol) to PVDF 
membranes (Immobilon-P, Millipore).  Membranes were incubated overnight in Tris 
buffered saline (TBST) containing 0.5% Tween 20, MgCl2  and 3% BSA at 4oC, and 
then incubated with primary antibodies (1 ug/ml in TBST with 3% BSA) for 2 hr at room 
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temperature.  Proteins were detected by using HRP-conjugated goat anti-mouse or 
anti-rabbit Ig (Amersham, Arlington Heights, IL) and developed with SuperSignal CL-
HRP Substrate (Pierce, Rockford, IL).  Chemiluminescence was detected by 
autoradiograph.   
 To examine tyrosine phosphorylation of DNAM-1, cells were stimulated or not 
with plastic-precoated mAbs for 2 min. and/or 100 mM sodium pervanadate for 10 min 
at 37oC. Cells were lysed in Tris-buffered saline (50 mM Tris, 150 mM NaCl, pH 8.0) 
containing 1% NP-40, and the protease and phosphatase inhibitors described above. 
Cell lysates were immunoprecipitated with control Ig, anti DNAM-1 mAb (DX11), anti-
Flag or anti-PTKs lck or fyn and proteins were separated by SDS-PAGE.  
Immunoprecipitates were immunoblotted, as described above, and then incubated with 
anti-phosphotyrosine 4G10 (1 ug/ml in TBST with 3% BSA) for 2 hr at room 
temperature.  Proteins were detected by using HRP-conjugated goat anti-mouse Ig. 
 For the analysis of tyrosine phosphorylation of DNAM-1 induced by mAbs 
and P815 cells, P815 cells were pre-coated with control Ig or anti-DNAM-1 
(DX11 mAb) and then incubated with NK clones derived from a LAD patient, as 
described previously (Shibuya et al., 1996). 
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Figure Legends 
 
Fig 1. NK cell clones from LAD patients are deficient in anti-DNAM-1 
induced cell-mediated cytotoxicity 
(A) CD3-CD56+ NK clones were established from a patient with Leukocyte 
Adhesion Deficiency (LAD).  The LAD NK clones lacked the expression of 
CD11a, CD11b, CD11c, and CD18 (i.e. LFA-1, Mac-1, and p150/95) (left).  
The CD18 cDNA was introduced in the LAD NK clone using an amphotropic 
retrovirus and NK cells stably expressing cell surface LFA-1 were sorted by flow 
cytometry and expanded.  Genetic transfer of CD18 into the LAD NK clone 
restored the expression of CD11a and CD18 (i.e. LFA-1) but these cells did not 
express CD11b or CD11c (i.e. MAC-1 and p150/95) (right). 
(B) NK clones from a healthy donor killed the Fc receptor-bearing P815 target in 
the presence of anti-DNAM-1 mAb (left panel).  LAD NK cell clones killed the 
P815 target in the presence of anti-CD16 mAb, but not anti-DNAM-1 mAb 
(center).  CD18 gene transfer into the LAD NK clone restored anti-DNAM-1 
mAb-induced cytolysis.  Anti-DNAM-1 induced killing was inhibited in the 
presence of F(ab')2 fragments of anti-CD18 mAb (left and right).   
(C) The LAD NK clone lacking the expression of LFA-1 (left panel) or the LAD NK 
clone expressing LFA-1 after CD18 gene transfer (right) were incubated for 2 min with 
P815 cells pre-coated with each mAb indicated.  Cells were then lysed in 1% NP-40 
buffer and immunoprecipitated with anti-DNAM-1.  The immunoprecipitates were 
analyzed by immunoblot using anti-phosphotyrosine (4G10) (upper) or anti-DNAM-1 
mAb (lower).  Tyrosine phosphorylation of DNAM-1 was not induced in the LAD NK 
clone (left), but was observed in the LAD clone expressing LFA-1 (right).  The 
tyrosine phosphorylation of DNAM-1 in the CD18 reconstituted LAD NK cell clone was 
abolished in the presence of F(ab')2 fragments of anti-CD18 mAb (right). 
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Fig 2. Association of LFA-1 with DNAM-1 in peripheral NK cells 
Resting peripheral blood CD3-CD56+ NK cells were lysed in 1% digitonin buffer 
and immunoprecipitated (IP) with control Ig, anti-CD18, CD11a, CD11b, CD11c 
or anti-DNAM-1.  The immunoprecipitates were analyzed by immunoblotting 
(IB) with anti-DNAM-1 mAb.  DNAM-1 was co-immunoprecipitated with CD11a 
and CD18, but not with CD11b and CD11c. 
 
Fig 3.   Anti-CD3 or PMA induced association of LFA-1 with DNAM-1 in 
peripheral T cells 
(A) Resting peripheral blood T cells were stimulated with plastic-coated cIg or 
anti-CD3 mAb for 2 min in the presence or absence of the PKC inhibitor 
GF109203X (1uM), or PMA (50 ng/ml) at 37oC for 2 hours.  The cells were 
lysed in 1% digitonin buffer and immunoprecipitated with anti-CD18 mAb or 
control Ig.  The immunoprecipitates were analyzed by immunoblotting with 
anti-DNAM-1 mAb.  CD18 co-immunoprecipitates DNAM-1 in T cells activated 
by anti-CD3 or PMA. 
(B)  Resting peripheral T cells were metabolically labeled with 
[32P]orthophosphate, stimulated with cIg, anti-CD3 mAb or PMA, lysed, and 
immunoprecipitated with anti-DNAM-1 mAb.  Treatment of resting T cells with 
either anti-CD3 mAb or PMA resulted in phosphorylation of DNAM-1. 
(C) Resting peripheral blood T cells were stimulated with plastic-coated control 
Ig or anti-CD3 mAb for 2 min. The cells were stimulated or not with pervanadate 
for 10 min at 37oC and lysed in the 1% digitonin buffer. The lysates were 
immunoprecipitated with anti-CD18 mAb or control Ig and analyzed by 
immunoblotting with anti-DNAM-1 mAb.  DNAM-1 was co-immunoprecipitated 
with LFA-1 in T cells activated by anti-CD3, but not in resting T cells, regardless 
of the stimulation with pervanadate. 
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Fig. 4 Role of Ser329 of DNAM-1 in the association of DNAM-1 with LFA-1 
(A)  Jurkat cells and NKL cells were lysed in the 1% digitonin lysis buffer and 
immunoprecipitated with anti-DNAM-1 mAb, anti-CD18 mAb or cIg.  The 
immunoprecipitates were analyzed by immunoblotting with anti-DNAM-1 mAb.  
DNAM-1 was co-immunoprecipitated with CD18 in Jurkat and NKL cells.  
(B) Jurkat cells were transfected with wild type or site-directed mutant (S-F329) 
DNAM-1, both tagged with the Flag epitope.  The transfectants were lysed in 
the 1% digitonin buffer and immunoprecipitated with anti-CD18 mAb or control 
Ig. The immunoprecipitates were analyzed by immunoblotting with anti-DNAM-1 
mAb or anti-Flag mAb.  CD18 was co-immunoprecipitated with wild type 
DNAM-1, but not with S-F329 DNAM-1. 
(C) Jurkat transfectants with wild type or site-directed mutant (S-F329) DNAM-1 
were metabolically labeled with [32P]orthophosphate and DNAM-1 proteins 
were immunoprecipitated with anti-Flag mAb. The DNAM-1 proteins in Jurkat 
cells transfected with WT DNAM-1, but not with S-F329 mutant DNAM-1, were 
phosphorylated.   
 
Fig 5. Relationship between LFA-1, DNAM-1, and the protein tyrosine 
kinase fyn 
(A) Resting peripheral blood T cells were stimulated with plastic-coated cIg, 
anti-CD3 mAb and/or anti-CD18 mAb for 2 min.  The cells were then lysed in 
the 1% NP-40 buffer and immunoprecipitated with cIg, anti-protein tyrosine 
kinases lck, -fyn, or anti-DNAM-1 mAb.  The immunoprecipitates were 
immunoblotted with anti-phosphotyrosine mAb 4G10.  Tyrosine 
phosphorylation of fyn and DNAM-1 was augmented by the stimulation with 
anti-CD18 in the combination with anti-CD3, but not by cross-linking with anti-
CD18 alone. 
(B) Resting peripheral blood T cells were stimulated with plastic-coated cIg or 
anti-CD3 mAb for 2 min.  Then the cells were stimulated or not with 
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pervanadate for 10 min at 37oC and lysed in 1% digitonin buffer.  The lysates 
were immunoprecipitated with cIg, anti-CD18 or anti-DNAM-1 and analyzed by 
immunoblotting with anti-fyn.  Fyn was co-immunoprecipitated with DNAM-1, 
but not with CD18, in T cells stimulated with pervanadate alone.  Co-
immunoprecipitation of  fyn with CD18 was always detected in T cells 
stimulated with anti-CD3 mAb. 
 
Fig 6. Y322 is required for pervanadate-induced phosphorylation of 
DNAM-1 
Jurkat cells were transfected with wild type or site-directed mutant Y-F322 
DNAM-1, both tagged with the Flag epitope.  Two days after transfection, 
Jurkat cells were stimulated with pervanadate for 10 min at 37oC and lysed in 
1% NP-40 buffer (left) or 1% digitonin buffer (right).  The lysates were 
immunoprecipitated with anti-Flag or cIg and analyzed by immunoblotting with 
anti-phosphotyrosine (4G10) or anti-fyn.  Wild type DNAM-1, but not Y-F322 
DNAM-1, was tyrosine phosphorylated (left).  Fyn was co-immunoprecipitated 
with both wild type and Y-F322 DNAM-1.  
 
Fig 7. Fyn is responsible for tyrosine phophorylation of DNAM-1 
COS 7 cells were co-transfected with wild-type or T-F322 mutant DNAM-1 and 
either with wild-type, kinase dead, or constitutively active fyn.  Two days after 
transfection, DNAM-1 proteins were immunoblotted with anti-phosphotyrosine.  
The wild-type DNAM-1 protein was tyrosine phosphorylated in the co-
transfectant with wild-type and constitutively active, but not kinase dead, fyn.  
By contrast,  the tyrosine phopshorylation of Y-F322 mutant DNAM-1 was not 
detected in the transfectant with any type of fyn (right).   
